Spiramycine Biogaran

Spiramycine Biogaran Uses, Dosage, Side Effects, Food Interaction and all others data.

Spiramycine Biogaran is a macrolide antibacterial that inhibits protein synthesis by irreversibly binding to the 50S subunit of the ribosomal subunit thus blocking the transpeptidation or translocation reactions of susceptible organisms resulting in stunted cell growth.

The absolute bioavailability of oral spiramycin is generally within the range of 30 to 40%. After a 1 g oral dose, the maximum serum drug concentration was found to be within the range 0.4 to 1.4 mg/L.

Trade Name Spiramycine Biogaran
Generic Spiramycin
Spiramycin Other Names Demycarosylturimycin H, Foromacidin A, Foromacidine A, Spiramycin 1, Spiramycin A, Spiramycin I
Type
Formula C43H74N2O14
Weight Average: 843.065
Monoisotopic: 842.514005071
Protein binding

Low level of protein binding (10-25%).

Groups Approved
Therapeutic Class Macrolides
Manufacturer
Available Country France
Last Updated: September 19, 2023 at 7:00 am
Spiramycine Biogaran
Spiramycine Biogaran

Uses

Acne vulgaris, Cryptosporidiosis, Protozoal infections, Susceptible infections, Toxoplasmosis

Spiramycine Biogaran is also used to associated treatment for these conditions: Bacterial Infections

How Spiramycine Biogaran works

The mechanism of action of macrolides has been a matter of controversy for some time. Spiramycine Biogaran, a 16-membered macrolide, inhibits translocation by binding to bacterial 50S ribosomal subunits with an apparent 1 : 1 stoichiometry. This antibiotic is a potent inhibitor of the binding to the ribosome of both donor and acceptor substrates. The primary mechanism of action is done by stimulation of dissociation of peptidyl-tRNA from ribosomes during translocation.I

Dosage

Spiramycine Biogaran dosage

Intravenous-

Toxoplasmosis, Cryptosporidiosis, Protozoal infections, Susceptible infections:

  • Adult: 1.5 million units by slow infusion every 8 hr, may double the dose in severe infections.

Oral-Cryptosporidiosis, Protozoal infections, Susceptible infections, Toxoplasmosis:

  • Adult: 6-9 million units/day in 2-3 divided doses, increased to 15 million units/day, given in divided doses for severe infections.
  • Child and neonates: Chemoprophylaxis of congenital toxoplasmosis: 50 mg/kg bid.

May be taken with or without food.

Side Effects

Nausea, vomiting, abdominal pain, diarrhoea; urticaria, pruritus, macular rashes. Transient paraesthesia may occur.

Toxicity

Cardiac toxicity, specifically QT prolongation (irregular heartbeat; recurrent fainting).
Cholestatic hepatitis (abdominal pain; nausea; vomiting; yellow eyes or skin).
Gastrointestinal toxicity, specifically acute colitis (abdominal pain and tenderness; bloody stools; fever).
Intestinal injury (abdominal pain and tenderness). Ulcerated esophagitis (chest pain; heartburn).

Precaution

Hepatic impairment; pregnancy and lactation. Monitor liver function. History of arrhythmias or predisposition to QT interval prolongation.

Interaction

Decreases carbidopa absorption and levodopa concentrations. Increased risk of ventricular arrhythmias when used with astemizole, cisapride and terfenadine. Risk of acute dystonia when used with fluphenazine

Food Interaction

  • No food interactions are expected.

Volume of Distribution

The tissue distribution of spiramycin is extensive. The volume of distribution is in excess of 300 L, and concentrations achieved in bone, muscle, respiratory tract and saliva exceed those found in serum. Spiramycine Biogaran showed high concentrations in tissues such as: lungs, bronchi, tonsils, and sinuses.

Elimination Route

The extent of absorption of Spiramycine Biogaran was shown to be incomplete. Oral bioavailability ranges from 30-39%. Spiramycine Biogaran has slower rate of absorption than Erythromycin. It has a high pKa (7.9) which could be a result of high degree of ionization in acidic medium of the stomach.

Half Life

Intravenous: Young persons (18 to 32 years of age): Approximately 4.5 to 6.2 hours. Elderly persons (73 to 85 years of age): Approximately 9.8 to 13.5 hours.

Oral: 5.5-8 hours, Rectal in children: 8 hours

Clearance

80% of the administered dose excreted in the bile, which makes the fecal-biliary route is the most important route of elimination. Enterohepatic recycling could also occur. Only 4 to 14% of an administered dose is eliminated through renal-urinary excretion route.

Elimination Route

Fecal-biliary route is the primary route of elimination. The secondary route is renal-urinary route.

Pregnancy & Breastfeeding use

Pregnancy Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.

Contraindication

Hypersensitivity.

Innovators Monograph

You find simplified version here Spiramycine Biogaran

Spiramycine Biogaran contains Spiramycin see full prescribing information from innovator Spiramycine Biogaran Monograph, Spiramycine Biogaran MSDS, Spiramycine Biogaran FDA label

FAQ

What is Spiramycine Biogaran used for?

Spiramycine Biogaran is used to treat a wide variety of bacterial infections. This medication is known as a macrolide antibiotic.Spiramycine Biogaran works by stopping the growth of bacteria. This antibiotic treats only bacterial infections.

How safe is Spiramycine Biogaran?

Spiramycine Biogaran 1.5 mg tablet is safe for kidney disease patients to use. No dosage change is recommended for the Spiramycine Biogaran 1.5mg Tablet. Liver - Consult the physician Limited information on the use of the Spiramycine Biogaran 1.5mg tablet in patients with liver disease is available.

What are the common side effects of Spiramycine Biogaran?

Indigestion, nausea, vomiting, diarrhea or stomach ache may occur. If any of these effects continue or become bothersome, inform your doctor. In the unlikely event you have an allergic reaction to this drug, seek medical attention immediately.

Is Spiramycine Biogaran safe during pregnancy?

Yes, Spiramycine Biogaran is safe to use in pregnancy. Spiramycine Biogaran is considered safe to use during pregnancy. Animal studies have shown little to no adverse effects on the developing baby; human studies, however, are minimal.

Is Spiramycine Biogaran safe during pregnancy?

Spiramycine Biogaran has less side effects and is recommended during breastfeeding period.

Is Spiramycine Biogaran a penicillin?

Spiramycine Biogaran proved to be equivalent to penicillin in the treatment of acute bacterial tonsillitis in adults.

Can I drive after taking Spiramycine Biogaran?

Spiramycine Biogaran normally does not affect your driving performance.

Does Spiramycine Biogaran cross placenta?

Spiramycine Biogaran is a macrolide antibiotic, which aims at the prevention of fetal infection. It does not cross the blood-placental barrier and, therefore, has no teratogenic effects to the fetus, or toxicity to the mother.

When is the best time to take Spiramycine Biogaran?

Spiramycine Biogaran is best taken on an empty stomach. To help clear up your infection completely, keep taking this medicine for the full time of treatment, even if you begin to feel better after a few days.

How to take Spiramycine Biogaran?

Tell your doctor if you have ever had any unusual or allergic reaction to Spiramycine Biogaran or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Is there any food or drink I need to avoid when taking Spiramycine Biogaran?

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

How to proper use of Spiramycine Biogaran?

Spiramycine Biogaran is best taken on an empty stomach.To help clear up your infection completely, keep taking Spiramycine Biogaran for the full time of treatment, even if you begin to feel better after a few days. If you stop taking Spiramycine Biogaran too soon, your symptoms may return.

What happens if I miss a dose of Spiramycine Biogaran?

If you miss a dose of  Spiramycine Biogaran, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

What happen if I overdose of Spiramycine Biogaran?

Symptoms of overdose may include nausea, vomiting, and diarrhea.

Is Spiramycine Biogaran an antibiotic?

Spiramycine Biogaran is a macrolide antibiotic, first isolated from Streptomyces ambofaciens.

Is spiramycin broad spectrum?

Spiramycine Biogaran is a broad-spectrum macrolide antibiotic effective against gram-negative and gram-positive bacteria as well as some Toxoplasma parasites. Spiramycine Biogaran is a mixture of Spiramycine Biogaran I, II, and III and has been used to study sepsis in mice.

*** Taking medicines without doctor's advice can cause long-term problems.
Share